Divi's Laboratories Limited (BOM:532488)
6,169.15
-19.05 (-0.31%)
At close: Feb 13, 2026
Divi's Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 103,140 | 93,600 | 78,450 | 77,670 | 89,598 | 69,694 |
Other Revenue | - | - | - | - | 0.9 | 0.7 |
Revenue | 103,140 | 93,600 | 78,450 | 77,670 | 89,599 | 69,695 |
Revenue Growth (YoY) | 13.61% | 19.31% | 1.00% | -13.31% | 28.56% | 29.20% |
Cost of Revenue | 39,550 | 37,250 | 33,520 | 32,740 | 31,662 | 24,771 |
Gross Profit | 63,590 | 56,350 | 44,930 | 44,930 | 57,938 | 44,924 |
Selling, General & Admin | 14,260 | 12,580 | 11,060 | 9,870 | 9,571 | 8,367 |
Other Operating Expenses | 15,360 | 14,050 | 11,780 | 11,370 | 9,526 | 7,853 |
Operating Expenses | 34,120 | 30,650 | 26,620 | 24,670 | 22,212 | 18,776 |
Operating Income | 29,470 | 25,700 | 18,310 | 20,260 | 35,726 | 26,148 |
Interest Expense | -180 | -20 | -30 | - | -3.7 | -3.9 |
Interest & Investment Income | 2,950 | 2,950 | 3,010 | 2,050 | 689.6 | 572.4 |
Currency Exchange Gain (Loss) | 1,310 | 480 | 300 | 1,300 | 405.8 | -43.8 |
Other Non Operating Income (Expenses) | 70 | 40 | 30 | 40 | 38.1 | 21.2 |
EBT Excluding Unusual Items | 33,620 | 29,150 | 21,620 | 23,650 | 36,856 | 26,694 |
Gain (Loss) on Sale of Investments | 50 | 50 | 50 | 50 | - | 26.5 |
Gain (Loss) on Sale of Assets | -40 | -40 | -40 | -10 | -20.5 | -59.6 |
Other Unusual Items | -740 | - | - | - | - | - |
Pretax Income | 32,890 | 29,160 | 21,630 | 23,690 | 36,835 | 26,660 |
Income Tax Expense | 8,100 | 7,250 | 5,630 | 5,450 | 7,231 | 6,818 |
Net Income | 24,790 | 21,910 | 16,000 | 18,240 | 29,605 | 19,843 |
Net Income to Common | 24,790 | 21,910 | 16,000 | 18,240 | 29,605 | 19,843 |
Net Income Growth | 19.93% | 36.94% | -12.28% | -38.39% | 49.19% | 44.15% |
Shares Outstanding (Basic) | 265 | 265 | 265 | 265 | 265 | 265 |
Shares Outstanding (Diluted) | 265 | 265 | 265 | 265 | 265 | 265 |
EPS (Basic) | 93.37 | 82.53 | 60.27 | 68.71 | 111.52 | 74.75 |
EPS (Diluted) | 93.37 | 82.53 | 60.27 | 68.69 | 111.52 | 74.75 |
EPS Growth | 19.95% | 36.93% | -12.26% | -38.41% | 49.19% | 44.16% |
Free Cash Flow | - | 2,150 | 2,580 | 19,860 | 11,986 | 10,367 |
Free Cash Flow Per Share | - | 8.10 | 9.72 | 74.81 | 45.15 | 39.05 |
Dividend Per Share | - | 30.000 | 30.000 | 30.000 | 30.000 | 20.000 |
Dividend Growth | - | - | - | - | 50.00% | 25.00% |
Gross Margin | 61.65% | 60.20% | 57.27% | 57.85% | 64.66% | 64.46% |
Operating Margin | 28.57% | 27.46% | 23.34% | 26.09% | 39.87% | 37.52% |
Profit Margin | 24.04% | 23.41% | 20.39% | 23.48% | 33.04% | 28.47% |
Free Cash Flow Margin | - | 2.30% | 3.29% | 25.57% | 13.38% | 14.88% |
EBITDA | 33,630 | 29,680 | 22,050 | 23,640 | 38,801 | 28,666 |
EBITDA Margin | 32.61% | 31.71% | 28.11% | 30.44% | 43.30% | 41.13% |
D&A For EBITDA | 4,160 | 3,980 | 3,740 | 3,380 | 3,075 | 2,518 |
EBIT | 29,470 | 25,700 | 18,310 | 20,260 | 35,726 | 26,148 |
EBIT Margin | 28.57% | 27.46% | 23.34% | 26.09% | 39.87% | 37.52% |
Effective Tax Rate | 24.63% | 24.86% | 26.03% | 23.00% | 19.63% | 25.57% |
Revenue as Reported | 107,520 | 97,120 | 81,840 | 81,120 | 90,737 | 70,320 |
Advertising Expenses | - | - | - | - | 1.6 | 0.7 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.